BE822929A - Preparations pharmaceutiques destinees a influencer la fixationet l'elimination de sels peu solubles de calcium - Google Patents

Preparations pharmaceutiques destinees a influencer la fixationet l'elimination de sels peu solubles de calcium

Info

Publication number
BE822929A
BE822929A BE151139A BE151139A BE822929A BE 822929 A BE822929 A BE 822929A BE 151139 A BE151139 A BE 151139A BE 151139 A BE151139 A BE 151139A BE 822929 A BE822929 A BE 822929A
Authority
BE
Belgium
Prior art keywords
elimination
salts
calcium
binding
influence
Prior art date
Application number
BE151139A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE822929A publication Critical patent/BE822929A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3869Polyphosphonic acids containing carboxylic acid or carboxylic acid derivative substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE151139A 1973-12-06 1974-12-04 Preparations pharmaceutiques destinees a influencer la fixationet l'elimination de sels peu solubles de calcium BE822929A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2360797A DE2360797C2 (de) 1973-12-06 1973-12-06 Pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
BE822929A true BE822929A (fr) 1975-06-04

Family

ID=5900065

Family Applications (1)

Application Number Title Priority Date Filing Date
BE151139A BE822929A (fr) 1973-12-06 1974-12-04 Preparations pharmaceutiques destinees a influencer la fixationet l'elimination de sels peu solubles de calcium

Country Status (7)

Country Link
US (1) US3962433A (xx)
BE (1) BE822929A (xx)
CA (1) CA1028955A (xx)
DE (1) DE2360797C2 (xx)
FR (1) FR2253527B1 (xx)
GB (1) GB1495733A (xx)
NL (1) NL7414946A (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2553962A1 (de) * 1975-12-01 1977-06-08 Henkel & Cie Gmbh Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5899490A (ja) * 1981-10-19 1983-06-13 Eisai Co Ltd リン酸アミド誘導体およびその製造方法ならびにそれを含有する医薬
IT1195993B (it) * 1984-01-12 1988-11-03 Gentili Ist Spa Forme farmaceutiche a base di difosfonati
US4553974A (en) * 1984-08-14 1985-11-19 Mayo Foundation Treatment of collagenous tissue with glutaraldehyde and aminodiphosphonate calcification inhibitor
US5258067A (en) * 1988-06-25 1993-11-02 Bayer Aktiengesellschaft Liquid for conditioning tooth or bone substance
DE3821578A1 (de) * 1988-06-25 1989-12-28 Bayer Ag Fluessigkeit zur konditionierung von zahn- oder knochensubstanz
DE3829961A1 (de) * 1988-09-03 1990-03-08 Bayer Ag Verfahren zur kontinuierlichen herstellung von 2-phosphonobutan-1,2,4-tricarbonsaeure und ihrer alkalimetallsalze
US5356887A (en) * 1990-01-31 1994-10-18 Merck & Co., Inc. Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
DE4141928A1 (de) * 1991-12-19 1993-06-24 Boehringer Mannheim Gmbh Neue phosphonobernsteinsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5760021A (en) * 1992-05-29 1998-06-02 The Procter & Gamble Company Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
US5731299A (en) * 1992-05-29 1998-03-24 The Procter & Gamble Company Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
EP0654035B1 (en) * 1992-08-07 1997-08-20 PHARMACIA & UPJOHN COMPANY Phosphonoacetic esters and acids as anti-inflammatories
CN1043423C (zh) * 1993-01-02 1999-05-19 曼海姆泊灵格股份公司 新膦酰基琥珀酸衍生物及其制备方法和含这些化合物的药物组合物
DE4320223A1 (de) * 1993-06-18 1994-12-22 Boehringer Mannheim Gmbh Neue Phosphonobernsteinsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6432413B1 (en) 1998-02-27 2002-08-13 Wayne State University Functional improvements in Fahr disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584124A (en) * 1968-12-24 1971-06-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue

Also Published As

Publication number Publication date
CA1028955A (en) 1978-04-04
US3962433A (en) 1976-06-08
NL7414946A (nl) 1975-06-10
GB1495733A (en) 1977-12-21
FR2253527B1 (xx) 1980-01-04
DE2360797A1 (de) 1975-06-26
DE2360797C2 (de) 1985-05-23
FR2253527A1 (xx) 1975-07-04

Similar Documents

Publication Publication Date Title
BE822930A (fr) Preparations pharmaceutiques ou cosmetiques destinees a influencer la fixation et l'elimination de sels de calcium peu solubles
BE822929A (fr) Preparations pharmaceutiques destinees a influencer la fixationet l'elimination de sels peu solubles de calcium
HK86679A (en) Dethiacephalosporanic acid derivatives and their preparation and use
BE751120A (fr) Perfectionnements relatifs a la preparation d'enzymes microbiens
BE800695A (fr) Preparations pharmaceutiques a administrer par voie orale contenant de l'agglutinine
BE803771A (fr) Derives de l'acide 4-hydroxy-3,5-di-alcoyl-phenyl-propionique, leur preparation et leur application
GB1404113A (en) Cyclopentyl sulphide derivatives their preparation and their use in pharmaceutical compositions
AU474129B2 (en) Improvements in or relating to anchors
CA1002522A (en) Derivatives of triiodo-aminobenzenecarboxylic acids and the preparation thereof
BE803754A (fr) Nouvelles compositions pharmaceutiques a base d'antibiotiques et d'acide pyrrolidone-carboxylique ou de ses derives
BE795474A (fr) Sels alcalins d'acides polyester-carboxyliques, et leur preparation
CA978383A (en) Mercapto-s-triazines and water-soluble salts to treat soil
EG10793A (en) Indole-carboxylic acid derivatives and the preparation thereof
AU468686B2 (en) Improvements in or relating to dentures
CA1015745A (en) 3-substituted-methyl-3-cephem-4-carboxylic acid derivatives and preparation thereof
CA991643A (en) 3-phenoxypropylamine derivatives and preparation thereof
ZA738187B (en) Pharmaceutical composition and preparation thereof
BE836650Q (fr) Perfectionnements a la preparation de pigments d'acide silicique precipites
BE769015A (fr) Preparation d'hydroxy-halogenopyridines et de leurs sels
AU466509B2 (en) Improvements in or relating to folding anchors
PH11943A (en) 2,2"-anhydro-1-b-d-arabinofuranosyl-5-fluorocytosine salts and process of preparation
ZA745656B (en) 6-trichloroacetamido-penicillanic acid derivatives and their preparation
CA912566A (en) Barbituric acid and hydantoin derivatives and preparation thereof
IL42717A0 (en) Mono-oxycarboxylate salts of bis-biguanidines and their preparation
CA894265A (en) 1-amino-3-hydroxyguanidine and its acid addition salts

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: HENKEL K.G.A.A.

Effective date: 19891231